← SynDRA
TALIPEXOLE
SynDRA canonical compound SYN0001167 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | DRD2 |
| Mechanism of action | Adrenergic receptor agonist |
| Indication | genitial herpes |
| Disease area | infectious disease |
All known targets
- DRD2
- ADRA2A
- ADRA1B
- ADRA1D
- ADRA2B
- ADRA2C
- Adra2a
- Adra2b
- Adra2c
- DRD3
- DRD4
- DRD5
Mechanisms of action (all sources)
- Dopamine receptor agonist
- Adrenergic receptor agonist
- DRD2 AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HRH3
- ADRA1A
- OPRD1
- HTR2C
- KCNH2
- KDM4E
- LMNA
- MAOA
- MAPT
- MC3R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRK1
- HTR2A
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- RAD52
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- HTR2B
- ADORA1
- ADORA2A
- HRH2
- ADORA3
- ADRB1
- ADRB2
- AGTR1
- ALDH1A1
- APEX1
- AVPR1A
- AVPR2
- BDKRB2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic alpha-Agonists
- Antidepressive Agents
- Central Nervous System Agents
- Dopamine Agents
- Dopamine Agonists
- Neurotransmitter Agents
- Psychotropic Drugs
Cross-references
Synonyms
- talipexole hydrochloride
- talipexole HCl
- domin
- Talipexol
- Talipexole [INN]
- Talipexolum [Latin]
- Talipexol [Spanish]
- UNII-7AM2J46Z1Y
- Domin
- 7AM2J46Z1Y
- CHEMBL279085
- Talipexole (INN)
- NCGC00163160-01
- DSSTox_CID_26321
- DSSTox_RID_81537
- DSSTox_GSID_46321
- Talipexolum
- 6-Allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo(4,5-d)azepine
- 6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepin-2-amine
- 6-prop-2-enyl-4,5,7,8-tetrahydro-[1,3]thiazolo[4,5-d]azepin-2-amine
- 4H-Thiazolo[4,5-d]azepin-2-amine,5,6,7,8-tetrahydro-6-(2-propen-1-yl)-
- BHT920
- DTXCID6026321
- RefChem:187312
- BHT-920
- B-HT-920
- CAS-101626-70-4
- TALIPEXOLE [MI]
- Biomol-NT_000038
- cid_5374
- TALIPEXOLE [WHO-DD]
- SCHEMBL49817
- BPBio1_001257
- GTPL5442
- orb1708424
- BDBM86053
- CHEBI:93327
- B-HT920
Look up TALIPEXOLE in the interactive SynDRA portal →